Neurotechnology company Cognito Therapeutics scores $73M to study Alzheimer's device

cafead

Administrator
Staff member
  • cafead   Mar 23, 2023 at 09:23: PM
via Cognito Therapeutics, a startup using visual and auditory stimulation to treat neurodegenerative disorders, scored $73 million in a Series B funding round led by FoundersX Ventures, bringing its total raise to $93 million.

article source
 

<